Global facial implant market size was valued at USD 1.74 billion in 2014. Rising incidences of sports-related facial injuries and demand for minimally invasive surgeries for the reconstruction of facial trauma are expected to grow over the forecast period. In addition, rising expenditure on healthcare, awareness pertaining to facial implants, and adoption of cosmetic surgery are some factors contributing to a growth in demand.
U.S. facial implant market, by material, 2012 - 2022 (USD Million)
According to a report published by the American Society of Plastic Surgeons, in the U.S. alone 15.6 million cosmetic procedures were performed in 2014 and the number is expected to grow a rate of over 3.0% every year. Furthermore, rising demand for facial rejuvenation procedures is also expected to uplift product usage over the forecast period.
As per a report published by the Department of Health in 2013, cosmetic procedures in the UK accounted for an annual expenditure of 2.3 billion in 2010. Growing prevalence of facial fractures and target disorders is further expected to boost this annual expenditure by 2022.
Polymer implants held the largest share in terms of revenue as of 2014 due to increased usage for deformity correction surgeries. Additionally, benefits associated with it including rigid support, flexibility, and biocompatibility are anticipated to propel the market growth. Solid silicone implants are frequently used for augmentation surgery.
On the contrary, biological materials are expected to register the fastest growth majorly owing to, greater resemblance to the body tissues enabling easy adoption. Furthermore, increasing investments pertinent to R&D of biocompatible implant manufacturing is also expected to increase facial implant penetration in the near future.
Injectables or fillers are expected to register lucrative growth of over 7.5% in the coming seven years owing to increasing demand for nonsurgical facial rejuvenation procedures, cost-effectiveness, and growing awareness pertaining to use of fillers for augmentation surgery.
As per the statistics published by The American Society of Plastic Surgeons (ASPS), facelift & eyelid surgery was the topmost cosmetic surgery performed in the U.S. in 2013. Botulinum Toxin Type A held the largest revenue share of fillers, as of 2014 in the U.S. alone and is expected to grow at a rate of over 6.0% annually.
The global procedural implants segment is expected to grow due to rising adoption of facial surgeries. Eyelid surgery dominated the overall procedure segment owing to increasing volume of aesthetic procedures for correcting vision, reducing bagginess, and remove extra skin from eyelids.
According to the American Society of Plastic Surgeons, near about 207,000 eyelids & 128,000 facelift procedures were performed in the U.S.in 2014 and are expected to grow over the forecast period. Facelift surgical procedure adoption is expected to gain momentum in the next seven years owing to, the increasing awareness pertaining to aesthetics especially in baby boomers.
The North America market was the largest in 2014 at over 50.0% owing to, the rising incidences of facial deformities due to extensive industrialization. Furthermore, the introduction of technologically advanced facial implants, high patient awareness levels, rising demand for minimally invasive surgeries, and presence of sophisticated healthcare infrastructure for facial surgery are some other growth imparting factors.
On the contrary, the presence of high untapped opportunities, rising patient awareness levels, economic development, and constantly improving healthcare infrastructure are some key factors driving the Asia Pacific market.
In addition, increasing medical tourism activities supported by low procedural costs in the emerging economies of India and China are expected to drive industry growth over the next seven years.
Players accounting for significant facial implant market share include Medartis AG, Eurosurgical, Wanhe Plastic Materials, Johnson & Johnson, TMJ Concepts, Zimmer-Biomet Inc., Implantech Associates Inc., Spectrums Design Medical, Stryker Corp., KLS Martin L.P., Hanson Medical, Inc., Sebbin, and Sientra Inc.
The industry is competitive in nature and manufacturers are engaged in rigorous R&D to develop cost-effective and efficient products for reconstructive surgery and trauma treatment. For instance, the 3D printed patient-specific implant developed by Oxford Performance Materials (OPM) in July 2015 and marketed by Zimmer Biomet Inc.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.
Contact us now to get our best pricing.
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure.
"The quality of research they have done for us has been excellent..."
With Covid-19 infections rising globally, the apprehension regarding a shortage of essential life-saving devices and other essential medical supplies in order to prevent the spread of this pandemic and provide optimum care to the infected also widens. In addition, till a pharmacological treatment is developed, ventilators act as a vital treatment preference for the COVID-19 patients, who may require critical care. Moreover, there is an urgent need for a rapid acceleration in the manufacturing process for a wide range of test-kits (antibody tests, self-administered, and others). The report will account for Covid19 as a key market contributor.